Share
Ashley Grossman - Feature

Collaboration Is Paramount: Ashley B. Grossman’s Transatlantic Legacy

Honored by both the Endocrine Society and the European Society of Endocrinology with the 2025 Transatlantic Alliance Award, Ashley B. Grossman, F.Med.Sci, has made significant contributions to endocrine research on both sides of the Atlantic. Endocrine News speaks with Grossman about what this award means to him, what drew him to endocrinology in the first...
Share

ENDO 2025: Day by Day

No doubt your days will be packed while you’re at San Francisco’s Moscone Center, weaving through the crowds as you make your way to various sessions and presentations at ENDO 2025. Here are just a few highlights – among hundreds – that might appeal to you. Saturday July 12 Stalk Lesions of the Pituitary Gland...
Share

Endocrine Society Proposes Research Efforts to Improve Treatment Options for People with Type 1 Diabetes

Scientific Statement aims to expand our research to advance the understanding of the cause and progression of type 1 diabetes.   A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes that should help with the development of new and improved treatment options. ...
Share

Advocacy In Action – July 2025

Congress Considers President’s Budget, NIH Funding   In May, the federal budget process for fiscal year 2026 (FY 2026) kicked off in earnest as the White House Office of Management and Budget released the President’s Budget Request (PBR) for the coming year. The PBR calls for an overall 22% cut in non-defense discretionary spending and drastic...
Share

New Guidelines Reexamine Hirsutism

A new set of clinical guidelines published in the Journal of Clinical Endocrinology & Metabolism is reshaping how physicians diagnose and treat hirsutism, a condition that causes excessive male-pattern hair growth in women. Affecting roughly 10% of women worldwide, hirsutism has long been viewed through a primarily cosmetic lens. But the updated recommendations emphasize a...
Share

Should  SGLT2 Inhibitors Be Stopped Before Emergency Surgery?

A new study entitled “Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users” published in JAMA Surgery calls into question the current guidelines advising doctors to pause a widely used class of diabetes drugs—sodium-glucose cotransporter 2 inhibitors (SGLT2i) — before surgery. The findings suggest the risk of developing postoperative euglycemic ketoacidosis (eKA), a serious and potentially...